QUBIS

VascVersa Ltd

Back to portfolio

We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.

Life Science

These cells are of the highest quality and potency, which allows them to be the starting point for a wide range of applications in regenerative medicine research and therapy.

VascVersa is based on research from The Queens University of Belfast and led by Christina O’Neill. 

Visit website

  • Life Science

    CV6 Therapeutics (NI) Ltd

    CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.

    Read more

  • Digital, Engineering

    Analytics Engines Ltd

    At Analytics Engines, we see data differently. Our expert team delivers creative, agile data solutions, which are as unique as the challenges they solve.

    Read more

  • Life Science

    Biocolor Ltd

    Biocolor designs, manufactures and distributes research tools for use by cell biology and bioengineering communities.

    Read more

  • Life Science

    Re–Vana Therapeutics Ltd

    Re–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.

    Read more